Current view: indications for extracorporeal lipid apheresis treatment (Q36028650)

11 August 2017

Current view: indications for extracorporeal lipid apheresis treatment (English)

1 reference

11 August 2017

Volker Schettler

1 reference

11 August 2017

C L Neumann

1 reference

11 August 2017

M Hulpke-Wette

1 reference

11 August 2017

G C Hagenah

1 reference

11 August 2017

E G Schulz

1 reference

11 August 2017

E Wieland

1 reference

11 August 2017

German Apheresis Working Group

1 reference

11 August 2017

1 June 2012

1 reference

Clinical research in cardiology supplements

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

15-19

1 reference

Creative Commons Attribution 2.0 Generic

11 August 2017

start time

20 March 2012

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

2 October 2017

Lipoprotein apheresis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

World apheresis registry 2003-2007 data.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Recommendations for the use of LDL apheresis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

A systematic review of LDL apheresis in the treatment of cardiovascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

State of the art of low-density lipoprotein apheresis in the year 2003.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Lipidfiltration--safe and effective methodology to perform lipid-apheresis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Adult Treatment Panel II versus Adult Treatment Panel III: what has changed and why?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Apheresis registry in France: indications, techniques, and complications. French Registry Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole Blood

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Genetic variants associated with Lp(a) lipoprotein level and coronary disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-012-0046-6

Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-012-0046-6

The German Lipid Apheresis Registry - remaining to be established

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-012-0046-6

Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-012-0046-6

The Canadian apheresis registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11789-012-0046-6

Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

In vitro evaluation of dextran sulfate cellulose beads for whole blood infusion low-density lipoprotein-hemoperfusion

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3374123

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

23 September 2018

1 reference

12 December 2020

Homozygous cutaneo-tendinous forms of hypercholesteremic xanthomatosis in an exemplary familial case. Trial of plasmapheresis ans heroic treatment

1 reference

12 December 2020

Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia

1 reference

12 December 2020

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)

1 reference

12 December 2020

Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies

1 reference

12 December 2020

Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group

1 reference

12 December 2020

10.1007/S11789-012-0046-6

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22528134

1 reference